Juan M. Melero-Martin

Department of Cardiac Surgery, Harvard Medical School

Affiliated withHarvard Medical School

Research Area

Biography

Juan M. Melero-Martin has not added Biography.
If you are Juan M. Melero-Martin and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 21	2011

Other Publications

Article	Year
Cryopreservation and in vitro expansion of chondroprogenitor cells isolated from the superficial zone of articular cartilage. Biotechnology progress\| PubMed ID: 15903255	2005
Optimal in-vitro expansion of chondroprogenitor cells in monolayer culture. Biotechnology and bioengineering\| PubMed ID: 16259002	2006
Expansion of chondroprogenitor cells on macroporous microcarriers as an alternative to conventional monolayer systems. Biomaterials\| PubMed ID: 16455134	2006
Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood\| PubMed ID: 16861344	2006
Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circulation research\| PubMed ID: 16973908	2006
In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood\| PubMed ID: 17327403	2007
Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. The Journal of clinical investigation\| PubMed ID: 18535669	2008
Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circulation research\| PubMed ID: 18556575	2008
Chapter 13. An in vivo experimental model for postnatal vasculogenesis. Methods in enzymology\| PubMed ID: 19022065	2008
In vivo monitoring of function of autologous engineered pulmonary valve. The Journal of thoracic and cardiovascular surgery\| PubMed ID: 20176213	2010
Host myeloid cells are necessary for creating bioengineered human vascular networks in vivo. Tissue engineering. Part A\| PubMed ID: 20218762	2010
Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors. Blood\| PubMed ID: 20453162	2010
Functional endothelial progenitor cells from cryopreserved umbilical cord blood. Cell transplantation\| PubMed ID: 20887663	2011
Vascular Stem Cells and Tumor Angiogenesis. Stem cells (Dayton, Ohio)\| PubMed ID: 21184502	2010
Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. The Journal of clinical investigation\| PubMed ID: 21505261	2011
Concise review: Vascular stem cells and tumor angiogenesis. Stem cells (Dayton, Ohio)\| PubMed ID: 21732475	2011
Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes. Journal of molecular and cellular cardiology\| PubMed ID: 21907210	2012
Induction of erythropoiesis using human vascular networks genetically engineered for controlled erythropoietin release. Blood\| PubMed ID: 21937702	2011
Fibroblast growth factor-2 facilitates rapid anastomosis formation between bioengineered human vascular networks and living vasculature. Methods (San Diego, Calif.)\| PubMed ID: 22326880	2012